#EULAR2022 OP0273 Difficult to treat RA (D2TRA): ⭐️Lower socioeconomic treatment ⭐️RF positivity ⭐️Higher inflammatory markers ⭐️ILD ⭐️Lower proportion on MTX, better response to JAKi and RTX @RheumNow